1. Home
  2. GOSS vs TG Comparison

GOSS vs TG Comparison

Compare GOSS & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • TG
  • Stock Information
  • Founded
  • GOSS 2015
  • TG 1988
  • Country
  • GOSS United States
  • TG United States
  • Employees
  • GOSS N/A
  • TG N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • TG Metal Fabrications
  • Sector
  • GOSS Health Care
  • TG Industrials
  • Exchange
  • GOSS Nasdaq
  • TG Nasdaq
  • Market Cap
  • GOSS 237.9M
  • TG 267.5M
  • IPO Year
  • GOSS 2019
  • TG 1989
  • Fundamental
  • Price
  • GOSS $0.96
  • TG $7.95
  • Analyst Decision
  • GOSS Strong Buy
  • TG
  • Analyst Count
  • GOSS 5
  • TG 0
  • Target Price
  • GOSS $9.20
  • TG N/A
  • AVG Volume (30 Days)
  • GOSS 1.0M
  • TG 120.7K
  • Earning Date
  • GOSS 03-04-2025
  • TG 11-08-2024
  • Dividend Yield
  • GOSS N/A
  • TG N/A
  • EPS Growth
  • GOSS N/A
  • TG N/A
  • EPS
  • GOSS N/A
  • TG N/A
  • Revenue
  • GOSS $105,322,000.00
  • TG $717,366,000.00
  • Revenue This Year
  • GOSS N/A
  • TG N/A
  • Revenue Next Year
  • GOSS N/A
  • TG N/A
  • P/E Ratio
  • GOSS N/A
  • TG N/A
  • Revenue Growth
  • GOSS N/A
  • TG N/A
  • 52 Week Low
  • GOSS $0.50
  • TG $3.98
  • 52 Week High
  • GOSS $1.60
  • TG $9.22
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 54.23
  • TG 57.20
  • Support Level
  • GOSS $0.83
  • TG $7.49
  • Resistance Level
  • GOSS $1.18
  • TG $8.03
  • Average True Range (ATR)
  • GOSS 0.10
  • TG 0.30
  • MACD
  • GOSS -0.01
  • TG 0.02
  • Stochastic Oscillator
  • GOSS 41.37
  • TG 80.92

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About TG Tredegar Corporation

Tredegar Corp through its subsidiaries engaged in the manufacture of Polyethylene Plastic films, Polyester Films, and Aluminum Extrusions. Polyethylene Plastic films manufacture plastic films, elastics and laminate materials which are utilized in personal care materials, surface protection films, and specialty and optical lighting applications. It operates through PE Films, Flexible Packaging Films, and Aluminum Extrusions segments. Aluminum Extrusions generates the majority of revenue and produces high-quality, soft-alloy, and medium-strength aluminum use for building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. It generates revenue from the United States, Asia, and Brazil.

Share on Social Networks: